• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用青霉胺治疗的威尔逊病与红斑狼疮:相关还是不同的病症?

Wilson's disease treated with penicillamine and lupus erythematosus: related or distinct entities?

作者信息

Dell'era L, Boati E, Nebbia G, Corona F

机构信息

Fondazione IRCCS Policlinico, Mangiagalli e Regina Elena, University of Milan, Milan, Italy.

出版信息

Minerva Pediatr. 2012 Feb;64(1):55-7.

PMID:22350045
Abstract

Systemic lupus erythematosus (SLE) has been reported to be associated to Wilson's disease, as a complication of treatment with penicillamine. Even though drug-induced lupus erythematosus (DILE) has some features in common with SLE, they are distinct entities. We report the case of a young girl who at the age of five had a diagnosis of Wilson's disease and she started therapy with penicillamine. Eight years after the beginning of therapy, she developed proteinuria, which was considered to be related to penicillamine. Two years later, she developed arthritis, malar rash and laboratory findings suggestive for lupus erythematosus. At the beginning her symptoms, due to the known association between penicillamine and DILE, were thought to be related to this treatment. In this hypothesis, she was referred to the Rheumatology Centre; zinc acetate was substituted for penicillamine and she started naproxen for the treatment of arthritis. Anyway, the subsequent clinical course and laboratory findings led us to a diagnosis of idiopathic SLE. A renal biopsy detected massive mesangiocapillary proliferation with subendothelial deposits (wire loops) and duplication of glomerular basement membrane (active diffuse global proliferative lupus nephritis, class IV G A). To our knowledge, this is the first report of an association between Wilson's disease and SLE.

摘要

据报道,系统性红斑狼疮(SLE)与威尔逊病有关,是青霉胺治疗的一种并发症。尽管药物性狼疮(DILE)与SLE有一些共同特征,但它们是不同的疾病实体。我们报告了一名年轻女孩的病例,她在5岁时被诊断为威尔逊病,并开始接受青霉胺治疗。治疗开始8年后,她出现蛋白尿,这被认为与青霉胺有关。两年后,她出现关节炎、蝶形红斑以及提示红斑狼疮的实验室检查结果。起初,由于已知青霉胺与DILE之间的关联,她的症状被认为与这种治疗有关。基于这一假设,她被转诊至风湿病中心;用醋酸锌替代了青霉胺,并开始使用萘普生治疗关节炎。然而,随后的临床病程和实验室检查结果使我们诊断为特发性SLE。肾脏活检发现大量系膜毛细血管增生伴内皮下沉积物(铁丝圈)和肾小球基底膜双轨征(活动性弥漫性全肾小球增生性狼疮性肾炎,IV级G A)。据我们所知,这是威尔逊病与SLE关联的首例报告。

相似文献

1
Wilson's disease treated with penicillamine and lupus erythematosus: related or distinct entities?用青霉胺治疗的威尔逊病与红斑狼疮:相关还是不同的病症?
Minerva Pediatr. 2012 Feb;64(1):55-7.
2
Penicillamine and the SLE syndrome.青霉胺与系统性红斑狼疮综合征
J Rheumatol Suppl. 1981 Jan-Feb;7:155-60.
3
[Lupus erythematosus due to penicillamine associated with Wilson's disease].[青霉胺所致红斑狼疮伴威尔逊病]
Ann Med Interne (Paris). 1971 Feb;122(2):269-73.
4
[Systemic lupus erythematosus induced by d-penicillamine in Wilson's disease: apropos of a case].[肝豆状核变性中D-青霉胺诱发的系统性红斑狼疮:附1例报告]
Med Clin (Barc). 1987 Apr 4;88(13):552-4.
5
Co-occurring Wilson's disease and non-penicillamine-induced systematic lupus erythematosus: a case report and literature review.共同发生的威尔逊病和非青霉胺诱导的系统性红斑狼疮:病例报告及文献复习。
Clin Rheumatol. 2021 Jun;40(6):2485-2490. doi: 10.1007/s10067-020-05463-z. Epub 2020 Oct 15.
6
Penicillamine induced lupus-like syndrome: a case report.青霉胺诱发的狼疮样综合征:一例报告。
J Microbiol Immunol Infect. 2000 Sep;33(3):202-4.
7
[A case of fulminant hepatic failure in Wilson's disease combined with systemic lupus erythematosus].[威尔逊病合并系统性红斑狼疮致暴发性肝衰竭 1 例]
Taehan Kan Hakhoe Chi. 2002 Mar;8(1):100-4.
8
[A syndrome similar to systemic lupus erythematosus caused by penicillamine in patients with Wilson's disease].[肝豆状核变性患者中由青霉胺引起的类似系统性红斑狼疮的综合征]
Bratisl Lek Listy. 1985 Sep;84(3):336-40.
9
Penicillamine associated pulmonary hemorrhage.青霉胺相关性肺出血。
J Rheumatol. 1986 Oct;13(5):963-6.
10
Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.在没有替代孤儿药(曲恩汀 - 锌)的情况下停用青霉胺:1例威尔逊病失代偿期肝硬化病例
J Clin Pharm Ther. 2007 Feb;32(1):101-7. doi: 10.1111/j.1365-2710.2007.00794.x.

引用本文的文献

1
Wilson's Disease-Crossroads of Genetics, Inflammation and Immunity/Autoimmunity: Clinical and Molecular Issues.威尔逊氏病——遗传学、炎症和免疫/自身免疫的交汇点:临床和分子问题。
Int J Mol Sci. 2024 Aug 20;25(16):9034. doi: 10.3390/ijms25169034.
2
Kidney involvement in Wilson's disease: a review of the literature.威尔逊病的肾脏受累:文献综述
Clin Kidney J. 2024 Mar 9;17(4):sfae058. doi: 10.1093/ckj/sfae058. eCollection 2024 Apr.
3
Prevalence and Significance of Autoantibody Seropositivity in Children with Wilson's Disease.
肝豆状核变性患儿自身抗体血清阳性的患病率及意义
Diagnostics (Basel). 2023 Feb 17;13(4):768. doi: 10.3390/diagnostics13040768.
4
The Role of Zinc in the Treatment of Wilson's Disease.锌在威尔逊病治疗中的作用。
Int J Mol Sci. 2022 Aug 18;23(16):9316. doi: 10.3390/ijms23169316.
5
Co-occurrence of Wilson's disease and systemic lupus erythematosus: a case report and literature review.Wilson 病与系统性红斑狼疮共存:病例报告及文献复习。
BMC Gastroenterol. 2021 May 21;21(1):229. doi: 10.1186/s12876-021-01814-5.
6
Nephrotic range proteinuria in an adolescent with a diagnosis of Wilson's disease: Answers.一名诊断为威尔逊氏病的青少年出现肾病范围蛋白尿:答案。
Pediatr Nephrol. 2021 Jul;36(7):2103-2106. doi: 10.1007/s00467-021-04961-9. Epub 2021 Feb 2.
7
Co-occurring Wilson's disease and non-penicillamine-induced systematic lupus erythematosus: a case report and literature review.共同发生的威尔逊病和非青霉胺诱导的系统性红斑狼疮:病例报告及文献复习。
Clin Rheumatol. 2021 Jun;40(6):2485-2490. doi: 10.1007/s10067-020-05463-z. Epub 2020 Oct 15.
8
Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases.药物再利用以改善风湿免疫性炎症性疾病的治疗。
Nat Rev Rheumatol. 2020 Jan;16(1):32-52. doi: 10.1038/s41584-019-0337-0. Epub 2019 Dec 12.
9
Wilson's disease combined with systemic lupus erythematosus: a case report and literature review.威尔逊病合并系统性红斑狼疮:一例报告及文献综述
BMC Neurol. 2018 Jun 15;18(1):85. doi: 10.1186/s12883-018-1085-5.
10
Advances in Treatment of Wilson Disease.肝豆状核变性的治疗进展
Tremor Other Hyperkinet Mov (N Y). 2018 Feb 28;8:525. doi: 10.7916/D841881D. eCollection 2018.